{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:44:44Z","timestamp":1789501484851,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1093\/toxsci\/kfs211","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T21:09:31Z","timestamp":1342213771000},"page":"456-468","source":"Crossref","is-referenced-by-count":47,"title":["Chronic Exposure to Rifaximin Causes Hepatic Steatosis in Pregnane X Receptor-Humanized Mice"],"prefix":"10.1093","volume":"129","author":[{"given":"Jie","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher W.","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank, J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,7,12]]},"reference":[{"key":"key\n\t\t\t\t20170508170809_CIT0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2009.03.011","article-title":"As a matter of fat","volume":"10","author":"Brookheart","year":"2009","journal-title":"Cell Metab."},{"key":"key\n\t\t\t\t20170508170809_CIT0002","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.510290612","article-title":"Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats","volume":"29","author":"Brunet","year":"1999","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508170809_CIT0003","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1476-5381.2010.01129.x","article-title":"Pregnane X receptor- and CYP3A4-humanized mouse models and their applications","volume":"163","author":"Cheng","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"key\n\t\t\t\t20170508170809_CIT0004","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1124\/dmd.109.027565","article-title":"Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity","volume":"37","author":"Cheng","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170508170809_CIT0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2012.03.003","article-title":"Pregnane X receptor as a target for treatment of inflammatory bowel disorders","author":"Cheng","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"key\n\t\t\t\t20170508170809_CIT0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.110.170225","article-title":"Therapeutic role of rifaximin in inflammatory bowel disease: Clinical implication of human pregnane X receptor activation","volume":"335","author":"Cheng","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170508170809_CIT0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosissup.2008.05.014","article-title":"Intestinally derived lipids: Metabolic regulation and consequences\u2014An overview","volume":"9","author":"Cianflone","year":"2008","journal-title":"Atheroscler. Suppl."},{"issue":"9","key":"key\n\t\t\t\t20170508170809_CIT0008","first-page":"4","article-title":"Non-absorbable antibiotics and small bowel bacterial overgrowth","volume":"24","author":"Corazza","year":"1992","journal-title":"Ital. J. Gastroenterol."},{"key":"key\n\t\t\t\t20170508170809_CIT0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1445-5994.1981.tb03746.x","article-title":"Lipid absorption and intestinal lipoprotein formation","volume":"11","author":"Green","year":"1981","journal-title":"Aust. NZ J. Med."},{"key":"key\n\t\t\t\t20170508170809_CIT0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: A nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"key\n\t\t\t\t20170508170809_CIT0011","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/mp800131d","article-title":"Activation of the nuclear receptor PXR decreases plasma LDL-cholesterol levels and induces hepatic steatosis in LDL receptor knockout mice","volume":"6","author":"Hoekstra","year":"2009","journal-title":"Mol. Pharm."},{"key":"key\n\t\t\t\t20170508170809_CIT0012","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1099\/jmm.0.028571-0","article-title":"Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile","volume":"60","author":"Huhulescu","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"key\n\t\t\t\t20170508170809_CIT0013","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.24751","article-title":"Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis","volume":"55","author":"Kalambokis","year":"2012","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508170809_CIT0014","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ajg.2011.72","article-title":"Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"key\n\t\t\t\t20170508170809_CIT0015","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.2174\/092986710792927822","article-title":"Triglyceride level affecting shared susceptibility genes in metabolic syndrome and coronary artery disease","volume":"17","author":"Kisfali","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"key\n\t\t\t\t20170508170809_CIT0016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00418-009-0608-y","article-title":"Localization, function and regulation of the two intestinal fatty acid-binding protein types","volume":"132","author":"Levy","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"key\n\t\t\t\t20170508170809_CIT0017","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1742-4658.2011.08432.x","article-title":"Cytochrome P450s in the synthesis of cholesterol and bile acids\u2013\u2013From mouse models to human diseases","volume":"279","author":"Lorbek","year":"2012","journal-title":"FEBS J."},{"key":"key\n\t\t\t\t20170508170809_CIT0018","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.121913","article-title":"Rifaximin is a gut-specific human pregnane X receptor activator","volume":"322","author":"Ma","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170508170809_CIT0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1345\/aph.1K436","article-title":"Rifaximin for treatment of hepatic encephalopathy","volume":"43","author":"Maclayton","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"key\n\t\t\t\t20170508170809_CIT0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.physbeh.2011.02.029","article-title":"CD36 as a lipid sensor","volume":"105","author":"Martin","year":"2011","journal-title":"Physiol. Behav."},{"key":"key\n\t\t\t\t20170508170809_CIT0021","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0b013e32834622a2","article-title":"Enteroendocrine cells and lipid absorption","volume":"22","author":"Mellitzer","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"key\n\t\t\t\t20170508170809_CIT0022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1155\/2011\/310675","article-title":"Diagnostic and prognostic molecular markers in hepatocellular carcinoma","volume":"31","author":"Minguez","year":"2011","journal-title":"Dis. Markers"},{"key":"key\n\t\t\t\t20170508170809_CIT0023","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/hep.22907","article-title":"A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte","volume":"49","author":"Moreau","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508170809_CIT0024","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cbi.2010.01.008","article-title":"Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile","volume":"184","author":"Moya","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"key\n\t\t\t\t20170508170809_CIT0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004610.pub3","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhea in adults","author":"Nelson","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"key\n\t\t\t\t20170508170809_CIT0026","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/17425250902973695","article-title":"Rifaximin pharmacology and clinical implications","volume":"5","author":"Ojetti","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"key\n\t\t\t\t20170508170809_CIT0027","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","article-title":"The current state of serum biomarkers of hepatotoxicity","volume":"245","author":"Ozer","year":"2008","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20170508170809_CIT0028","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-61779-821-4_4","article-title":"Protein solubilization: Attend to the choice of lysis buffer","volume":"869","author":"Peach","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"key\n\t\t\t\t20170508170809_CIT0029","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543780902780175","article-title":"Review of rifaximin as treatment for SIBO and IBS","volume":"18","author":"Pimentel","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"key\n\t\t\t\t20170508170809_CIT0030","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1210\/me.2007-0196","article-title":"Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-gamma coactivator 1alpha in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c","volume":"21","author":"Ponugoti","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"key\n\t\t\t\t20170508170809_CIT0031","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/mol.107.041012","article-title":"Regulatory cross-talk between drug metabolism and lipid homeostasis: Constitutive androstane receptor and pregnane X receptor increase Insig-1 expression","volume":"73","author":"Roth","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"key\n\t\t\t\t20170508170809_CIT0032","doi-asserted-by":"crossref","first-page":"914","DOI":"10.5551\/jat.4929","article-title":"Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia","volume":"17","author":"Sandoval","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"key\n\t\t\t\t20170508170809_CIT0033","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.molimm.2006.04.021","article-title":"Nuclear receptors in human immune cells: expression and correlations","volume":"44","author":"Schote","year":"2007","journal-title":"Mol. Immunol."},{"key":"key\n\t\t\t\t20170508170809_CIT0034","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cca.2010.08.003","article-title":"Triglycerides and gallstone formation","volume":"411","author":"Smelt","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"key\n\t\t\t\t20170508170809_CIT0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e328333a1dd","article-title":"The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease","volume":"20","author":"Sookoian","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"key\n\t\t\t\t20170508170809_CIT0036","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1194\/jlr.M017376","article-title":"Deficiency of PXR decreases atherosclerosis in ApoE-deficient mice","volume":"52","author":"Sui","year":"2011","journal-title":"J. Lipid Res."},{"key":"key\n\t\t\t\t20170508170809_CIT0037","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170508170809_CIT0038","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2006.74.1060","article-title":"A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea","volume":"74","author":"Taylor","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"key\n\t\t\t\t20170508170809_CIT0039","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/DDDT.S11290","article-title":"Current and emerging drugs for the treatment of inflammatory bowel disease","volume":"5","author":"Triantafillidis","year":"2011","journal-title":"Drug Des. Devel. Ther."},{"key":"key\n\t\t\t\t20170508170809_CIT0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jinf.2010.11.004","article-title":"Rifaximin intake leads to emergence of rifampin-resistant staphylococci","volume":"62","author":"Valentin","year":"2011","journal-title":"J. Infect."},{"key":"key\n\t\t\t\t20170508170809_CIT0041","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1748-1716.2009.01970.x","article-title":"AMP-activated protein kinase in the regulation of hepatic energy metabolism: From physiology to therapeutic perspectives","volume":"196","author":"Viollet","year":"2009","journal-title":"Acta Physiol. (Oxf.)"},{"key":"key\n\t\t\t\t20170508170809_CIT0042","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol. Int."},{"key":"key\n\t\t\t\t20170508170809_CIT0043","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2217\/14622416.9.11.1695","article-title":"PXR: A xenobiotic receptor of diverse function implicated in pharmacogenetics","volume":"9","author":"Zhang","year":"2008","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20170508170809_CIT0044","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170508170809_CIT0045","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.M511116200","article-title":"A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway","volume":"281","author":"Zhou","year":"2006","journal-title":"J. Biol. Chem."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/129\/2\/456\/16684563\/kfs211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T22:27:11Z","timestamp":1561933631000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article-lookup\/doi\/10.1093\/toxsci\/kfs211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,12]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,7,12]]},"published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfs211","relation":{},"ISSN":["1096-0929","1096-6080"],"issn-type":[{"value":"1096-0929","type":"electronic"},{"value":"1096-6080","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,12]]}}}